Enjoy complimentary customisation on priority with our Enterprise License!
The global spatial genomics and transcriptomics market size is estimated to grow by USD 619.21 million, at a CAGR of 11.22% between 2023 and 2028.
Spatial genomics and transcriptomics play a crucial role in developing innovative therapeutic approaches, leveraging extensive and complex data generation. The growing adoption of these techniques is propelled by user-friendly analysis tools for drug discovery. These emerging fields enable scientists to capture gene expression information along with the spatial context of tissue samples, facilitating the profiling of clinical samples to map molecular tissue taxonomy and localize cell types, providing valuable insights into disease progression. Hence, the increase in the adoption of spatial genomics and transcriptomics in drug discovery and development will drive the growth of the market during the forecast period.
Technavio has segmented the market into Application, Product, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the translation research segment will be significant during the forecast period. Spatial genomics and transcriptomics revolutionize translational research by offering insights into tissue spatial organization. In cancer, they identify distinct tumor microenvironments, guiding personalized therapies. For neurological disorders, spatial transcriptomics illuminates brain gene expression, aiding targeted therapies. In infectious diseases, spatial genomics maps pathogen distribution, enhancing precision in treatment interventions.
Get a glance at the market contribution of various segments Download PDF Sample
The translation research segment was valued at USD 369.70 million in 2018. Moreover, spatial genomics and transcriptomics play a key role in immunotherapy research. By characterizing the spatial distribution of immune cells and their gene expression profiles within the tumor microenvironment, researchers can tailor immunotherapies to improve the immune response against cancer. Consequently, spatial genomics and transcriptomics in translational research have revolutionized the understanding of diseases by providing spatially resolved molecular information. Thus, such factors will drive the growth of the translational research segment of the market during the forecast period.
Spatial genomics and transcriptomics, cutting-edge technologies, study gene expression within tissue spatial organization. Crucial consumables include spatially barcoded slides or chips for gene expression patterns, integrating microfluidics. Transcriptomics employs spatially barcoded beads capturing RNA positions, enabling comprehensive spatial analysis of multiple genes. Consumables like primers and probes contribute to genetic material preparation, ensuring reliable, reproducible spatially resolved data and advancing understanding of biological tissue organization. Thus, such factors will drive the growth of the consumables segment of the market during the forecast period.
Spatial genomics and transcriptomics rely on advanced instruments like sequencing platforms, microscopy, flow cytometry, and mass spectrometry for precise gene expression mapping in tissues. Key tools include spatial transcriptomics platforms with barcoded slides, RNA in-situ hybridization, and single-cell RNA sequencing. High-resolution microscopy captures detailed spatial information, while microarray-based and NGS platforms analyze transcript abundance. Emerging technologies, including spatially barcoded beads and droplet-based systems, enhance scalability and sensitivity, forming a sophisticated toolkit that aids researchers in unraveling spatial gene expression complexities for therapeutic advancements in drug discovery. Thus, such factors will drive the growth of the instruments segment of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American spatial genomics and transcriptomics market growth is fueled by numerous laboratories, research facilities, and pharmaceutical firms, particularly in the US and Canada. Thermo Fisher Scientific, among other market players, contributes to the region's market expansion through innovative technologies. The competitive US market sees vendors concentrating on proprietary advancements for applications like oncology and rare disease diagnosis. Targeting end-users like biopharmaceutical companies and research institutions, vendors aim to penetrate cancer-related translational and clinical research, presenting opportunities for revenue growth and expanded product applications in this dynamic research landscape. Hence, such factors are expected to drive market growth in this region during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
10X Genomics Inc.: The company offers spatial genomics and transcriptomics solutions such as Visium Spatial Gene Expression that allows researchers to map the activity of thousands of genes within intact tissue sections while preserving both their spatial context and morphology.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
Rising product launches and strategic alliances by companies are the key factors driving market growth. Market players are implementing various strategies, like new product launches, collaborations, and partnerships, to maintain and boost their position in the market. For Example, in April 2023, Bio-Techne Corporation entered into a partnership with Lunaphore Technologies SA to design and develop the world's first automated spatial omics multi-workflow. This system will be designed to provide complete flexibility in panel design.
Similarly, Illumina Inc. entered into a strategic research collaboration with AstraZeneca plc in October 2022 to accelerate drug target discovery by combining their strengths in Al-based genome interpretation and genomic analysis techniques with industry expertise. Thus, the increasing number of new product launches and strategic alliances by companies will drive the growth of the market during the forecast period.
Increasing use of spatial omics for biomarker identification is the primary trend shaping market growth. Biomarkers play an important role in simplifying drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs. Additionally, biomarkers are widely used in diagnosing diseases like cancer, cardiovascular disease, and neurological disease. Also, aligning with market trends and analysis biomarkers has enabled scientists and medical researchers to get a better understanding and locate the target gene in the disease pathway and progression.
Furthermore, the drug discovery of new biomarkers in the diagnosis of various diseases, particularly cancer, has brought about revolutionary changes in medicine. In addition, continuous developments in sequencing technologies have increased the efficacy of biomarkers in disease detection and their utilization in disease diagnoses. Hence, spatial genomics and transcriptomics have the potential to aid in novel clinical-relevant biomarker discovery in the coming years; hence, the market in focus will grow significantly during the forecast period.
The lack of a workforce with expertise in handling spatial genomics and transcriptomics is a challenge that affects market growth. Spatial genomics and transcriptomics need skilled professionals, like researchers, and laboratory technicians, who can conduct spatial genomics and transcriptomics. Their duties also include understanding the underlying genomic mechanisms and biological entities. Performing experiments for spatial genomics and transcriptomics is a labor-intensive process.
Furthermore, the lack of adequate knowledge, training, and courses on spatial genomics and transcriptomics available for the detection and staging of a disease is one of the prime factors limiting the number of students who opt to become laboratory technicians. Consequently, the lack of a skilled workforce is a restraining factor for the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. The market growth and forecasting focus on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends opportunities from 2018 to 2028.
|
Spatial Genomics and Transcriptomics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
162 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 11.22% |
|
Market Growth 2024-2028 |
USD 619.21 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
9.31 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
10X Genomics Inc., Akoya Biosciences Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., RareCyte Inc., Rebus Biosystems Inc., Resolve BioSciences GmbH, S2 Genomics Inc., Seven Bridges Genomics Inc., Singular Genomics System Inc., Ultivue Inc., Veranome Biosystems LLC, Vizgen Corp., and PerkinElmer Inc |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
